Product Images Escitalopram Oxalate

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 6 images provide visual information about the product associated with Escitalopram Oxalate NDC 50090-2752 by A-s Medication Solutions, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

1 - escitalopram oxalate tablets 1

1 - escitalopram oxalate tablets 1

This is a table that shows the treatment-emergent adverse reactions observed with a frequency greater than 2% and higher than the placebo for major depressive disorder. It includes the percentage of occurrence for each reaction for the drug Escitalopram Oxalate compared to the placebo, such as dry mouth, sweating, diarrhea, indigestion, fatigue, insomnia, sinusitis, and others. It also provides additional information regarding the denominator used for males and females.*

2 - escitalopram oxalate tablets 2

2 - escitalopram oxalate tablets 2

The table shows the most common adverse reactions observed in patients taking Escitalopram for Generalized Anxiety Disorder. The adverse reactions are primarily related to the nervous system, the gastrointestinal system, and psychiatric disorders. The most common adverse reactions with a frequency greater than placebo are dry mouth, increased sweating, headache, nausea, somnolence, and ejaculation disorder.*

1 - escitalopram oxalate tablets 3

1 - escitalopram oxalate tablets 3

logo - escitalopram oxalate tablets 4

logo - escitalopram oxalate tablets 4

1 - escitalopram oxalate tablets 5

1 - escitalopram oxalate tablets 5

Label Image - lbl500902752

Label Image - lbl500902752

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.